The four RTK subgroups, G1/EGFR, G2/FGFR3, G5/PDGFRA and G6/Multi-RTK, totaled over 50% of the cases, underscoring the importance of RTK signaling for glioblastoma pathogenesis. The gene discussed is PDGFRA; the disease is glioblastoma.